mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
0.9 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.019 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |